Skip to main content

Table 2 Number of joints from a total of 2970 evaluated joints at three different points of time and comparison of number of joints with increased FOI signal and detection by US according to detection by clinical examination

From: Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

 

FOI

US/PD

 

Any signal (n = 947)

Composite image (n = 530)

Phase 1 (n = 396)

Phase 2 (n = 783)

Phase 3 (n = 180)

Any signal (n = 527)

Effusion (n = 430)

Synovitis (n = 375)

Hyperperfusion (n = 120)

Signal in clinically active joints (n = 519)

320 (33.8%/61.7%)a

205 (38.7%/39.5%)

161 (40.7%/31.0%)

277 (35.4%/53.4%)

81 (45.0%/15.6%)

239 (45.4%/46.0%)

211 (49.1%/40.7%)

164 (43.7%/31.6%)

47 (39.2%/9.0%)

Signal in clinically inactive joints (n = 2451)

627 (66.2%/25.6%)

325 (61.3%/13.3%)

235 (59.3%/9.6%9)

506 (64.6%/20.6%)

99 (55.0%/4.0%)

288 (54.6%/11.8%)

219 (51.0%/8.9%)

211 (56.2%/8.6%)

73 (60.8%/3.0%)

  1. Data on US examination were available for 2550 joints in total
  2. FOI fluorescence optical imaging, PD Power Doppler mode, US ultrasonography
  3. aPercentages refer to columns/rows